Health
U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…
By Reuters Staff
FILE PHOTO: A sign at an AstraZeneca site in Macclesfield, Britain, May 19, 2014. REUTERS/Phil Noble/File Photo
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very signif…
-
Noosa News24 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News21 hours agoQueensland government to introduced artificial intelligence teaching tool Corella to all state high schools
-
Business23 hours agoHow to turn $500 a month into $500,000 with ASX shares
-
General16 hours agoAustralia urged to give AUKUS sub ‘commitments’ to US in event of war